Journey Upstream Spawns New Research Models

Think outside the cage." That's all it takes to understand why some researchers are moving away from mouse models and diving into transgenic fish research, according to biologist Richard N. Winn of the University of Georgia. Investigators bucking the mammalian tide come from all sectors of biological research, and, in addition to Winn, include National Academy of Sciences (NAS) member Richard B. Setlow, senior biophysicist at Brookhaven National Laboratory; Elwood A. Linney, professor of microbi

Written byA. J. S. Rayl
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

These researchers have been lured, they say, by the research power inherent in fish. These prolific vertebrates are being shown to have a remarkably similar biology to mice, and, as models, fish provide high-quality data. "The objective, always, is to get good statistics and get them rapidly," notes Setlow, "and fish allow you to do that."

Fish models offer several distinct advantages over mice. They produce large numbers of offspring more quickly, and the vast species variety allows for enhanced comparison studies. Also, fish cost less to maintain than do mammals, and they attract less attention from animal-rights activists.

Although acquiring funding is an upstream journey, investigators using transgenic fish for environmental toxicology and biomedical studies have obtained National Institutes of Health grants. "The environmental health aspects to which these model organisms can contribute is huge," says Carvan, who has developed transgenic zebrafish sensitive to pollutants.1

Linney is also developing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies